{"id":69,"date":"2020-09-22T14:52:00","date_gmt":"2020-09-22T14:52:00","guid":{"rendered":"http:\/\/wallstreetresearch.org\/wsr\/?p=69"},"modified":"2026-10-29T21:47:27","modified_gmt":"2026-10-29T21:47:27","slug":"wallstreet-research-invites-you-to-a-webinar-featuring-founder-and-ceo-of-jaguar-health-inc-lisa-conte","status":"publish","type":"post","link":"https:\/\/wallstreetresearch.org\/wsr\/wallstreet-research-invites-you-to-a-webinar-featuring-founder-and-ceo-of-jaguar-health-inc-lisa-conte\/","title":{"rendered":"WallStreet Research Invites You to a Webinar Featuring Founder and CEO of Jaguar Health, Inc. Lisa Conte on Sept 29"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Tuesday, Sept 29th, 11:00 AM PST (2:00 PM EST) &#8211; <strong>Jaguar&nbsp;Health, Inc.<\/strong>&nbsp;(\u201cJaguar\u201d or \u201cthe Company\u201d), listed on NASDAQ: JAGX, is&nbsp;a commercial stage pharmaceuticals company focused on developing novel,&nbsp;plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Company&#8217;s wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals from plants harvested responsibly from rainforest areas. Their Mytesi\u00ae&nbsp;(crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV\/AIDS on antiretroviral therapy and the only oral plant-based prescription medicine approved under FDA Botanical Guidance.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In September 2020,&nbsp;Jaguar&nbsp;launched the Entheogen Therapeutics Initiative to support the discovery and development of novel, plant-based medicines derived from psychoactive plants for treatment of mood disorders, neuro-degenerative diseases, addiction, and other mental&nbsp;health&nbsp;disorders<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"280\" height=\"263\" src=\"https:\/\/wallstreetresearch.org\/wsr\/wp-content\/uploads\/2020\/10\/Mytesi.jpg\" alt=\"\" class=\"wp-image-70\"\/><\/figure><\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Lisa Conte<\/strong>\u00a0is the founder, president and chief executive officer, and a member of the board of directors, of\u00a0Jaguar\u00a0Health, a commercial-stage pharmaceuticals company committed to discovering, developing and commercializing plant-based prescription medicines for urgent global\u00a0health\u00a0needs.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Visit <a href=\"https:\/\/jaguar.health\/\" target=\"_blank\" rel=\"noopener\">https:\/\/jaguar.health\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tuesday, Sept 29th, 11:00 AM PST (2:00 PM EST) &#8211; Jaguar&nbsp;Health, Inc.&nbsp;(\u201cJaguar\u201d or \u201cthe Company\u201d), listed on NASDAQ: JAGX, is&nbsp;a commercial stage pharmaceuticals company focused on developing novel,&nbsp;plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI &hellip; <a href=\"https:\/\/wallstreetresearch.org\/wsr\/wallstreet-research-invites-you-to-a-webinar-featuring-founder-and-ceo-of-jaguar-health-inc-lisa-conte\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"wsr_event_date":"2020-09-29","wsr_event_start":"14:00","wsr_event_end":"","wsr_event_mode":"online","wsr_event_venue":"","wsr_event_address":"","wsr_event_url":"","wsr_event_speakers":"Lisa Conte","footnotes":""},"categories":[1],"tags":[11,13,54],"class_list":["post-69","post","type-post","status-publish","format-standard","hentry","category-events","tag-lisa-conte","tag-mytesi","tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/posts\/69","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/comments?post=69"}],"version-history":[{"count":7,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/posts\/69\/revisions"}],"predecessor-version":[{"id":169,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/posts\/69\/revisions\/169"}],"wp:attachment":[{"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/media?parent=69"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/categories?post=69"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/tags?post=69"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}